Eve Burstein
Stock Analyst at Bernstein
(2.25)
# 2,662
Out of 4,893 analysts
23
Total ratings
38.46%
Success rate
3.87%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $145 → $125 | $121.30 | +3.05% | 4 | Apr 16, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $161.75 | +23.65% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $100.13 | +44.81% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $349.21 | +3.09% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $55.31 | +62.72% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $51.04 | -31.43% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $419.88 | +47.66% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.48 | +68.92% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $13.57 | +62.12% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $97.44 | +13.92% | 1 | Sep 28, 2023 |
Agilent Technologies
Apr 16, 2025
Maintains: Market Perform
Price Target: $145 → $125
Current: $121.30
Upside: +3.05%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $161.75
Upside: +23.65%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $100.13
Upside: +44.81%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $349.21
Upside: +3.09%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $55.31
Upside: +62.72%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $51.04
Upside: -31.43%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $419.88
Upside: +47.66%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.48
Upside: +68.92%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $13.57
Upside: +62.12%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $97.44
Upside: +13.92%